OWH Intramural Research ProgramThe FDA OWH Intramural Research Program awards research grants for studies to address regulatory research questions to include: (1) health conditions and diseases that solely or disproportionately affect women; and (2) the identification and understanding of sex differences related to the safety or efficacy of FDA-regulated products.
Phase 1CompletedCompletedA. FY 2016 Projects (new awards)1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchersFY15 Q3Completed6/10/20152. Complete review of Quad Charts for development of full proposalFY15 Q4Completed8/30/20153. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewersFY16 Q2Completed2/11/20164. Issue award notices and execute funding agreements with FDA researchers for selected intramural studiesFY16 Q2Completed3/28/2016B. Ongoing Projects1. FDA researchers submit mid-year progress reports for OWH reviewFY16 Q3Completed8/15/20162. FDA researchers submit end of year progress reports for OWH reviewFY17 Q1Completed3/1/2017
Phase 2CompletedCompletedA. FY 2016 Projects (new awards)1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchersFY16 Q3Completed5/16/20162. Complete review of Quad Charts for development of full proposalFY16 Q4Completed7/11/20163. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewersFY17 Q1Completed11/30/20164. Issue award notices and execute funding agreements with FDA researchers for selected intramural studiesFY17 Q2Completed1/1/2017B. Ongoing Projects1. FDA researchers submit mid-year progress reports for OWH reviewFY16 Q3Completed5/1/20162. FDA researchers submit end of year progress reports for OWH reviewFY17 Q1Completed11/1/2016
Phase 3CompletedCompletedA. FY 2018 Projects (new awards)1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchersFY17 Q3Completed4/14/20172. Complete review of Quad Charts for development of full proposalFY17 Q3Completed6/26/20173. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewersFY18 Q1Completed12/18/20174. Issue award notices and execute funding agreements with FDA researchers for selected intramural studiesFY18 Q1Completed2/2/2018B. Ongoing Projects1. FDA researchers submit mid-year progress reports for OWH reviewFY17 Q3<i>(TBD)</i>Completed5/1/20172. FDA researchers submit end of year progress reports for OWH reviewFY18 Q1Completed11/1/2017
Phase 4DelayedOn TrackA. FY 2019 Projects (new awards)1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchersFY18 Q2Completed4/2/20182. Complete review of Quad Charts for development of full proposalFY18 Q3Completed7/2/20183. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewersFY19 Q1Completed12/21/20184. Issue award notices and execute funding agreements with FDA researchers for selected intramural studiesFY19 Q2Completed2/25/2019B. Ongoing Projects1. FDA researchers submit mid-year progress reports for OWH reviewFY18 Q2Completed5/1/20182. FDA researchers submit end of year progress reports for OWH reviewFY19 Q1<i>5/1/2019</i>Completed10/1/2019
Phase 5CompletedCompletedA. FY 2020 Projects (new awards)1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchersFY19 Q2Completed4/2/20192. Complete review of Quad Charts for development of full proposalFY19 Q3Completed7/1/20193. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewersFY20 Q1Completed12/17/20194. Issue award notices and execute funding agreements with FDA researchers for selected intramural studiesFY20 Q2Completed2/28/2019B. Ongoing Projects1. FDA researchers submit mid-year progress reports for OWH reviewFY19 Q2Completed5/1/20192. FDA researchers submit end of year progress reports for OWH reviewFY21 Q1Completed11/1/2020
Phase 6On TrackOn TrackA. FY 2021 Projects (new awards)1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchersFY20 Q2Completed4/21/20202. Complete review of Quad Charts for development of full proposalFY20 Q3Completed7/1/20203. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewersFY21 Q1Completed2/15/20204. Issue award notices and execute funding agreements with FDA researchers for selected intramural studiesFY21 Q2On TrackB. Ongoing Projects1. FDA researchers submit mid-year progress reports for OWH reviewFY20 Q3Completed5/1/20202. FDA researchers submit end of year progress reports for OWH reviewFY21 Q1Completed11/1/2020
http://www.fda.gov/AboutFDA/Transparency/track/ucm206688.htmFDA-TRACK OC Office of Women's Health Dashboard